Article
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone
19 Mar 2007
Abstract excerpt
Relapse following remission induction chemotherapy remains a barrier to survival in approximately 20% of children suffering from acute lymphoblastic leukemia (ALL). To investigate the mechanism of relapse, 27 matched diagnosis and relapse ALL samples were analyzed for clonal populations using polymerase chain reaction (PCR)-based detection of multiple antigen receptor gene rearrangements. These clonal markers...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
